Your browser doesn't support javascript.
loading
High dose of epinephrine does not improve survival of children with out-of-hospital cardiac arrest: Results from the French National Cardiac Arrest Registry.
Recher, Morgan; Canon, Valentine; Lockhart, Marguerite; Lafrance, Martin; Hubert, Hervé; Leteurtre, Stéphane.
Affiliation
  • Recher M; Pediatric Intensive Care Unit, CHU Lille, Lille, France.
  • Canon V; ULR 2694 - METRICS: Évaluation des technologies de santé et des pratiques médicales, Univ. Lille, CHU Lille, Lille, France.
  • Lockhart M; ULR 2694 - METRICS: Évaluation des technologies de santé et des pratiques médicales, Univ. Lille, CHU Lille, Lille, France.
  • Lafrance M; French National Out-of-Hospital Cardiac Arrest Registry Research Group - Registre électronique des Arrêts Cardiaques, Lille, France.
  • Hubert H; Pediatric Intensive Care Unit, CHU Lille, Lille, France.
  • Leteurtre S; ULR 2694 - METRICS: Évaluation des technologies de santé et des pratiques médicales, Univ. Lille, CHU Lille, Lille, France.
Front Pediatr ; 10: 978742, 2022.
Article in En | MEDLINE | ID: mdl-36275073
ABSTRACT

Objectives:

The pediatric resuscitation guidelines recommend the use of 0. 01 mg kg-1 epinephrine during a cardiac arrest; an epinephrine dose higher than that is not recommended. The first aim of this study was to determine the administration rate of high epinephrine dose during pediatric out-of-hospital cardiac arrest. The second aim was to compare the survival status in patients who received high or standard doses of epinephrine.

Methods:

This was a multicenter comparative post-hoc study conducted between January 2011 and July 2021 based on the French National Cardiac Arrest Registry data. All prepubescent (boys < 12 years old, girls < 10 years old) victims of an out-of-hospital cardiac arrest were included. To compare survival status and control bias, patients who received a high epinephrine dose were matched with those who received a standard epinephrine dose using propensity score matching.

Results:

The analysis included 755 patients; 400 (53%) received a high dose and 355 (47%) received a standard dose of epinephrine. The median dose (mg kg-1) per bolus was higher in the high-dose group than that in the standard dose group (0.04 vs. 0.01 mg kg-1, P < 0.001). Before matching, there was no between-group difference in the 30-day survival rate or survival status at hospital discharge. Matching yielded 288 pairs; there was no between-group difference in the 30-day survival rate or survival at hospital discharge (High dose, n = 5; standard dose, n = 12; Odds ratios 2.40, 95% confidence interval 0.85-6.81). Only 2 patients in the standard dose group had a good neurological outcome.

Conclusion:

More than 50% of the patients did not receive the recommended epinephrine dose during resuscitation. There was no association between patients receiving a high dose or standard dose of epinephrine with the 30-day survival or survival status at hospital discharge. Collaboration across multiple cardiac arrest registries is needed to study the application of pediatric guidelines.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Front Pediatr Year: 2022 Document type: Article Affiliation country: Publication country: CH / SUIZA / SUÍÇA / SWITZERLAND

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Front Pediatr Year: 2022 Document type: Article Affiliation country: Publication country: CH / SUIZA / SUÍÇA / SWITZERLAND